Risk Factors for Failure of OPAT (Outpatient Parenteral Antimicrobial Therapy) in Veterans with Staphylococcus aureus Bacteremia
نویسندگان
چکیده
To identify risk factors for failure of OPAT (outpatient parenteral antimicrobial therapy) among veterans with SAB (Staphylococcus aureus bacteremia), a retrospective review was conducted of all patients receiving OPAT for SAB between 01/2011-09/2013 at a large, tertiary-care VA (Veterans’ Affairs) medical center. Treatment failure was defined as incomplete therapy, therapy extension, infection relapse, or hospital admission or surgical intervention within 60 days of therapy completion. Of 118 SAB patients treated with OPAT, 101 met inclusion criteria. Treatment failure occurred in 36 (35.6%) patients. In multivariate analysis, heart failure (OR 3.67; CI 1.13-12.0), previous OPAT (OR 14.1; CI 2.02-97.8), immunosuppression (OR 10.5; CI 1.74-63.3), and treatment with daptomycin (OR 9.56; CI 1.89-48.4) were independently associated with failure. A trend toward lower failure rates was seen in the community living center, a VA long-term care facility possessing its own infectious diseases consultation service. In veterans with SAB, specific health factors were associated with higher rates of OPAT failure. Given the morbidity and cost of SAB treatment failures, similar analyses may benefit other large OPAT programs to optimize the selection of patients and settings in which successful treatment will most likely occur.
منابع مشابه
764Risk Factors for Failure of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB)
Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB) John Veillette, PharmD; Leslie Bittner, PharmD, BCPS; Marion Skalweit, MD, PhD; Usha Stiefel, MD; Christopher Burant, PhD; Amy Hirsch, PharmD, BCPS; Sharanie Sims, PharmD, BCPS (AQ-ID); Pharmacy, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH; Medicine, Louis Stokes Cleveland Departme...
متن کاملOutpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
OBJECTIVES We describe failure rates of 198 patients with bone and joint infection (BJI), including prosthetic joint infection and diabetic foot osteomyelitis, managed through the Glasgow centre for outpatient parenteral antibiotic therapy (OPAT) over a period of 4 years. Outcomes following initial intravenous antimicrobial therapy and a median follow-up time of 60 weeks are described. PATIEN...
متن کاملComparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin vs. Non-Vancomycin Anti-MRSA Therapy
متن کامل
1300OPAT Administration in the Homeless Population
Background. Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat serious infections. The IDSA recommends assessing “the functioning of utilities, safety issues, cleanliness, substance abuse, access to transportation and social strife” prior to initiation of OPAT. Because of these foreseen barriers, OPAT is infrequently offered to homeless patients, and little is know...
متن کامل730A Retrospective Comparison of Self – Administered Ceftriaxone vs Cefazolin for Methicillin-Susceptible Staphylococcus Aureus Bacteremia in an Outpatient Antibiotic Therapy Setting.
Background. MSSA bacteremia is a common cause of community-acquired and hospital-acquired infections with significant morbidity and mortality. Ceftriaxone is a third generation cephalosporin with activity against gram positive and gram negative aerobic bacteria including MSSA. It is well tolerated and offers significant cost reduction with its once daily dosing in the outpatient setting. Althou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016